Cargando…
The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients
This study investigates the association between the treatment with hydroxychloroquine and mortality in patients admitted with COVID-19. Routinely recorded, clinical data, up to the 24th of April 2020, from the 2075 patients with COVID-19, admitted in 17 hospitals in Spain between the 1st of March an...
Autores principales: | Ayerbe, Luis, Risco-Risco, Carlos, Ayis, Salma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526068/ https://www.ncbi.nlm.nih.gov/pubmed/32997237 http://dx.doi.org/10.1007/s11739-020-02505-x |
Ejemplares similares
-
Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients?
por: Ayerbe, Luis, et al.
Publicado: (2021) -
The association between treatment with heparin and survival in patients with Covid-19
por: Ayerbe, Luis, et al.
Publicado: (2020) -
Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients
por: Bahl, Amit, et al.
Publicado: (2021) -
Predicting mortality in hospitalized COVID-19 patients
por: Tirandi, Amedeo, et al.
Publicado: (2022) -
Hospital characteristics associated with COVID-19 mortality: data from the multicenter cohort Brazilian Registry
por: Souza-Silva, Maira Viana Rego, et al.
Publicado: (2022)